ADA and myeloid sarcoma: These considerations warrant further investigations on how genetic variants of ADA affect the enzyme’s activity (together with the above immunological parameters) in MS patients and further studies exploring different SNPs of ADA gene are required to better characterize the relationship between ADA genetic variability and MS pathogenesis.